Abbreviations

List of Abbreviations
Abbreviation Definition
ACC American College of Cardiology
ACCORD

Action to Control Cardiovascular Risk in Diabetes trials; a trial that examines the effects of intensive glycaemic control on cardiovascular events in people with type 2 diabetes who had either established cardiovascular disease or additional cardiovascular risk factors (NCT00000620)

ACG American College of Gastroenterology
ACR American College of Rheumatology
ACS Acute Coronary Syndrome
ADE Adverse Drug Event
ADL Activities of Daily Living
ADVANCE

Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation; a trial that examines the effects of intensive glucose control on macrovascular and microvascular events in people with type 2 diabetes (NCT00145925)

ADWE Adverse Drug Withdrawal Event
AF Atrial Fibrillation
AFF Atypical Femoral Fracture
AGREE II Appraisal of Guidelines for Research and Evaluation II
AHA American Heart Association
AIMS Abnormal Involuntary Movement Scale
ASPREE

ASPirin in Reducing Events in the Elderly; a trial that examines the effects of low-dose aspirin on all-cause mortality in healthy older people (NCT01038583)

ATC Anatomical Therapeutic Chemical (Classification System)
AV Atrioventricular
BMD Bone Mineral Density
BP Blood Pressure
BPH Benign Prostatic Hyperplasia
BPRS Brief Psychiatric Rating Scale
BPSD Behavioural and Psychological Symptoms of Dementia
BWSQ Benzodiazepine Withdrawal Symptom Questionnaire
CAC Coronary Artery Calcium
CANMAT Canadian Network for Mood and Anxiety Treatments
CBR Consensus-Based Recommendation
CBT Cognitive Behavioural Therapy
CEASE

Current medicines, Elevated risk, Assess, Sort, Eliminate; a clinical mnemonic developed to aid deprescribing

CGM Continuous Glucose Monitoring
CI Confidence Interval
CKD Chronic Kidney Disease
COPD Chronic Obstructive Pulmonary Disease
COX Cyclo-oxygenase
CRP C-Reactive Protein
CT Computed Tomography
CTX C-Terminal Telopeptide
CV Cardiovascular
CVD Cardiovascular Disease
DANTON Discontinuation of ANtihypertensive Treatment in Older people with dementia living in a Nursing home (a deprescribing trial)
DAPT Dual Antiplatelet Therapy
DBI Drug Burden Index
DBP Diastolic Blood Pressure
DCM Dementia Care Mapping
DISCUS Dyskinesia Identification System Condensed User Scale
DLB Dementia with Lewy Bodies
DXA Dual-Energy X-ray Absorptiometry
EBR Evidence-Based Recommendation
EF Ejection Fraction
EQ-5D EuroQol 5-Dimension
EQ-5D-5L EuroQol 5-Dimension 5-Level
ERASE

Evaluate, Resolved conditions, Ageing normally, Select targets, Eliminate; clinical mnemonics developed to aid deprescribing

ESR Erythrocyte Sedimentation Rate
FLEX

Fracture Intervention Trial Long-Term Extension; a trial that examines the long-term safety and efficacy of oral alendronate in postmenopausal women who previously received alendronate in conjunction with the fracture intervention trial (NCT00398931)

FLOW

Evaluate Renal Function with Semaglutide Once Weekly; a trial that investigates the effects of semaglutide, an once-weekly glucagon-like peptide-1 receptor agonist, on kidney outcomes in people with chronic kidney disease and type 2 diabetes (NCT03819153)

FVC Forced Vital Capacity
GDG Guideline Development Group
GDMT Guideline-Directed Medical Therapy
GI Gastrointestinal
GINA Global Initiative for Asthma
GORD Gastro-Oesophageal Reflux Disease
GPGP Good Palliative-Geriatric Practice; an implicit tool for deprescribing
GPS Good Practice Statement
GRADE Grading of Recommendations Assessment, Development and Evaluation
GSM Genitourinary Syndrome of Menopause
HFpEF Heart Failure with preserved Ejection Fraction
HFmrEF Heart Failure with mildly reduced Ejection Fraction
HFrEF Heart Failure with reduced Ejection Fraction
HR Hazard Ratio
ICS Inhaled Corticosteroids
INR International Normalised Ratio
IPSS International Prostate Symptom Score
IV Intravenous
LABA Long-Acting Beta-Agonist
LAMA Long-Acting Muscarinic Antagonist
LSC Least Significant Change
LUTS Lower Urinary Tract Symptoms
MACE Major Adverse Cardiovascular Event
MADRS Montgomery-Asberg Depression Rating Scale
mcg microgram
mg milligram
MD Mean Difference
MHT Menopausal Hormone Therapy
MI Myocardial Infarction
MMSE Mini-Mental State Examination
MRONJ Medication-Related Osteonecrosis of the Jaw
NHMRC National Health and Medical Research Council
NNT Number Needed to Treat
NPI Neuropsychiatric Inventory
NPI-NH Neuropsychiatric Inventory Nursing Home Version
NRS Numeric Rating Scale
NSAID Non-steroidal Anti-Inflammatory Drug
OAC Oral Anticoagulant
25[OH]D 25-hydroxyvitamin D
OR Odds Ratio
P1NP Procollagen Type 1 N Propeptide
P2Y12 Purinergic Receptor P2Y12
PBS Pharmaceutical Benefits Scheme
PCI Percutaneous Coronary Intervention
PDD Parkinson's Disease Dementia
PIM Potentially Inappropriate Medicine
PPI Proton Pump Inhibitor
PREVENTABLE

Pragmatic Evaluation of Events and Benefits of Lipid Lowering in Older Adults; a trial that examines the effects of statins on community-dwelling older people without cardiovascular diseases or dementia (NCT04262206)

PROMIS Patient-Reported Outcomes Measurement Information System
PSQI Pittsburgh Sleep Quality Index
QoL Quality of Life
QOLAD Quality of life in Alzheimer's Dementia
QUALID Quality of Life in Late Stage of Dementia score
QUALIDEM Quality of Life for People with Dementia
RA Rheumatoid Arthritis
RACGP Royal Australian College of General Practitioners
RCT Randomised Controlled Trial
RLS Restless Legs Syndrome
RR Relative Risk
SAPT Single Antiplatelet Therapy
SBP Systolic Blood Pressure
SD Standard Deviation
SELECT

Semaglutide Effects on Cardiovascular Outcomes in People with Overweight or Obesity; a trial that investigates the effects of semaglutide on cardiovascular outcomes in people with obesity without diabetes (NCT03574597)

SIB Severe Impairment Battery
SMB Standardised Mean Difference
SNRI Serotonin-Norepinephrine Reuptake Inhibitors
SoF Summary of Findings
SSRI Selective Serotonin Reuptake Inhibitors
STALD Sheffield Test for Acquired Language Disorders
STAREE

STAtins in Reducing Events in the Elderly; a trial that examines the effects of statin on disability-free survival and major cardiovascular events amongst healthy elderly people (NCT02099123)

STOPDAPT-3

ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-3 Study; a trial that examines aspirin-free strategy (prasugrel monotherapy without aspirin) after percutaneous coronary intervention (NCT04609111)

START Screening Tool to Alert to Right Treatment
SVT Supraventricular Tachycardia
TCA Tricyclic Antidepressants
TPV Total Prostatic Volume
TURP Transurethral Resection of the Prostate
UKPDS

United Kingdom Prospective Diabetes Study

United Kingdom Prospective Diabetes Study; a trial that examines the effects of intensive glycaemic control on the incidence of complications

ULT Urate-Lowering Therapy
UPDRS Unified Parkinson's Disease Rating Scale
VADT

Veterans Affairs Diabetes Trial

Veterans Affairs Diabetes Trial; a trial that examines the effects of intensive glycaemic control on cardiovascular events in people with long-standing type 2 diabetes mellitus

5Ms Mind, Mobility, Medicines, Multicomplexity, and (what) Matters (most)